Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tianma Xiongling Zhixuan is a traditional Chinese medicine (TCM) formulation primarily used in the management of hypertension and related vascular conditions. It is typically administered as a tablet and contains multiple herbal ingredients, with Gastrodia elata (Tianma) being a key component. Preclinical studies have shown that this formulation can lower blood pressure and improve vascular remodeling in spontaneously hypertensive rats, suggesting antihypertensive effects possibly through modulation of vascular function and reduction of target organ damage[1][2][3][9][10]. Clinical trials are ongoing to evaluate its efficacy and safety in patients with essential hypertension[4]. The precise mechanism of action is not fully elucidated but likely involves multiple pathways associated with blood pressure regulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Tianma Xiongling Zhixuan.